NEW YORK (GenomeWeb News) – Hologic reported after the close of the market on Monday that its fiscal second-quarter revenues increased 30 percent year over year, driven by the inclusion of sales from its Gen-Probe business, which Hologic acquired at the end of July.

The Bedford, Mass.-based company brought in revenues of $612.7 million for the three months ended March 31, compared to $471.2 million a year ago, but it missed the average Wall Street estimate of $639.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.